{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:07:08Z","timestamp":1794330428139,"version":"4.9.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070860"],"award-info":[{"award-number":["82070860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82161138026"],"award-info":[{"award-number":["82161138026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022e07020049"],"award-info":[{"award-number":["2022e07020049"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0806102"],"award-info":[{"award-number":["2022YFA0806102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.xcrm.2023.101257","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T10:34:23Z","timestamp":1698834863000},"page":"101257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese"],"prefix":"10.1016","volume":"4","author":[{"given":"Xi","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erfei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101257_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver\u00a0disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101257_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic\u00a0fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhepr.2019.05.009","article-title":"The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A\u00a0real-world patient-reported outcomes study","volume":"1","author":"Balp","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.xcrm.2023.101257_bib5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101257_bib6","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2023.101257_bib7","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.mayocp.2015.06.013","article-title":"Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"90","author":"Spengler","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.xcrm.2023.101257_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.xcrm.2023.101257_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2021.11.012","article-title":"MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis","volume":"76","author":"Noureddin","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/gutjnl-2022-327498","article-title":"Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis","volume":"72","author":"Angelini","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2023.101257_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1365-2036.2010.04480.x","article-title":"A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients","volume":"32","author":"Anty","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2023.101257_bib13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/hep.22241","article-title":"A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients","volume":"47","author":"Campos","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101257_bib14","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2023.101257_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib16","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/sj.onc.1206220","article-title":"Subtractive immunization using highly metastatic human tumor cells identifies SIMA135\/CDCP1, a 135\u00a0kDa cell surface phosphorylated glycoprotein antigen","volume":"22","author":"Hooper","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101257_bib17","doi-asserted-by":"crossref","first-page":"E6912","DOI":"10.1073\/pnas.1704008114","article-title":"CD318 is a ligand for CD6","volume":"114","author":"Enyindah-Asonye","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101257_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154604","article-title":"Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers","volume":"132","author":"Lim","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101257_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41589-021-00783-w","article-title":"Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1","volume":"17","author":"Kryza","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2023.101257_bib20","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1038\/onc.2016.7","article-title":"CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer","volume":"35","author":"Wright","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.xcrm.2023.101257_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110459","article-title":"Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients","volume":"17","author":"Zeybel","year":"2021","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2023.101257_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31865-w","article-title":"Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome","volume":"8","author":"Lovric","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.101257_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202104373","article-title":"Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis","volume":"9","author":"Zeybel","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2023.101257_bib24","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.1222435110","article-title":"Identification of CDCP1 as a hypoxia-inducible factor 2alpha (HIF-2alpha) target gene that is associated with survival in clear cell renal cell carcinoma patients","volume":"110","author":"Emerling","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101257_bib25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1158\/1541-7786.MCR-13-0587","article-title":"Oncogenic Ras\/ERK signaling activates CDCP1 to promote tumor invasion and metastasis","volume":"12","author":"Uekita","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101257_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101226","article-title":"Regulation of Fibrotic Processes in the Liver by ADAM Proteases","volume":"8","author":"Schmidt-Arras","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2023.101257_bib27","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1158\/0008-5472.CAN-13-2995","article-title":"ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway","volume":"74","author":"Lin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101257_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41419-020-2295-5","article-title":"Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease","volume":"11","author":"Han","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2023.101257_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.molmed.2016.08.007","article-title":"Caveolin-1 Function in Liver Physiology and Disease","volume":"22","author":"Fernandez-Rojo","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101257_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112700","article-title":"ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis","volume":"20","author":"Foglia","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101257_bib31","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3389\/fimmu.2020.01916","article-title":"Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases","volume":"11","author":"Magnusson","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101257_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103147","article-title":"Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes","volume":"63","author":"Gummesson","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2023.101257_bib33","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/db20-1054","article-title":"Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes","volume":"70","author":"Herder","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2023.101257_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90843-x","article-title":"Inflammation-related plasma protein levels and association with adiposity measurements in young adults","volume":"11","author":"Klevebro","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.101257_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2021.10.029","article-title":"Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study","volume":"76","author":"Rinella","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib36","article-title":"Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.101257_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"2017","author":"He","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.xcrm.2023.101257_bib38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S2468-1253(20)30252-1","article-title":"A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study","volume":"5","author":"Harrison","year":"2020","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101257_bib39","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2023.101257_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101257_bib41","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101257_bib42","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2023.101257_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","article-title":"Blood pressure and the new ACC\/AHA hypertension guidelines","volume":"30","author":"Flack","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.xcrm.2023.101257_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in\u00a0early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2023.101257_bib45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2023.101257_bib46","article-title":"A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes","volume":"4","author":"Diaz-Canestro","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2023.101257_bib47","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21-Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2023.101257_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1373\/clinchem.2010.155184","article-title":"Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans","volume":"57","author":"Yu","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.xcrm.2023.101257_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaike's Information Criterion (AIC): The general theory and its analytical extensions","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.xcrm.2023.101257_bib50","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2015.37","article-title":"Decision curve analysis","volume":"313","author":"Fitzgerald","year":"2015","journal-title":"JAMA"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123004342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T01:00:12Z","timestamp":1770858012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123004342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666379123004342"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101257","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101257"}}